HISTORY: 70 y.o. MALE PRESENTS WITH H/O S/P DLB LUNG TRANSPLANT ON 5/23/16. INTRO -OP PT DOWN FOR UNKNOWN TIME PRIOR EEG.  PT WITH??? SZ ACTIVITY.  PT WAS IN OR WHEN TREMORING STARTED UNDER SEDATION DON'T KNOW WHAT  MEDICATIONS: Current Facility-Administered Medications: sodium chloride 0.9 % injection (flush) 10 mL magnesium sulfate IVPB 4 g 100 mL HYDROmorphone (DILAUDID) injection 0.5 mg cycloSPORINE (NEORAL) 100 mg/mL microemulsion solution 125 mg aspirin EC tablet 81 mg sodium chloride 0.9 % injection (flush) 10 mL sodium chloride 0.9 % injection (flush) 10 mL norepinephrine (LEVOPHED) 16 mg/250 mL (64 mcg/mL) in NSS infusion ceFEPIme (MAXIPIME) 2 g in dextrose 5 % 100 mL IVPB metroNIDAZOLE (FLAGYL) IVPB 500 mg vancomycin (VANCOCIN) 1,000 mg in sodium chloride 0.9 % 250 mL IVPB MB+ lidocaine (PF) (XYLOCAINE) 10 mg/mL (1 %) injection 5 mL heparin (5000 units/mL) injection 5,000 Units sodium chloride 0.9 % infusion valGANciclovir (VALCYTE) solution 450 mg chlorhexidine (PERIDEX) 0.12 % solution 15 mL predniSONE (DELTASONE) tablet 5 mg [START ON 8/24/2016] amphotericin B lipid (ABELCET) 50 mg nebulizer solution  nystatin (MYCOSTATIN) 100,000 unit/mL suspension 500,000 Units tamsulosin (FLOMAX) 24 hr capsule 0.8 mg albuterol (PROVENTIL) nebulizer solution 5 mg Water Liqd 250 mL atorvastatin (LIPITOR) tablet 10 mg gabapentin (NEURONTIN) capsule 300 mg heparin (PF) 100 unit/mL flush 250 Units insulin lispro (HumaLOG) injection 2-10 Units dextrose 50% injection 25 mL dextrose 50% injection 50 mL glucagon (human recombinant) (GLUCAGEN) injection 1 mg isoniazid (NYDRAZID) tablet 300 mg pantoprazole (PROTONIX) injection 40 mg pyridoxine (vitamin B6) (B-6) tablet 50 mg sertraline (ZOLOFT) tablet 50 mg sodium chloride 0.9 % injection (flush) 2 mL vancomycin 50 mg/mL oral solution 125 mg acetaminophen (TYLENOL) tablet 650 mg albuterol (PROVENTIL) nebulizer solution 2.5 mg ondansetron (PF) (ZOFRAN) injection 4 mg   SEDATION: None  TECHNIQUE: A 21 channel electroencephalogram (EEG) was recorded using the International 10-20 system with T1/T2 electrodes and utilized a NicOne system. This was a technically satisfactory record and included a single channel of EKG.   DAY 1 (8/19/2016, 21:09 - 8/20/2016, 11:17AM)  BACKGROUND: The background is continuous and symmetric but poorly organized. Background consists of diffuse theta more than delta with occasional admixed faster frequencies. There is no posterior dominant rhythm or AP organization.  There is severe generalized slowing. Spontaneous eyeblinks are noted.  EPILEPTIFORM ACTIVITY: Occasional frontally-predominant diffuse sharp waves with triphasic morphology.  OTHER PAROXYSMAL ACTIVITY (NON-EPILEPTIFORM):  None  ACTIVATION PROCEDURES: Hyperventilation and photic stimulation are not performed.  EVENTS: There are no clinical or electrographic events captured during this study.  HEART RATE: A heart rate of 66 bpm is captured on a single EKG lead.  IMPRESSION: This is an abnormal routine EEG due to: 1. Moderate generalized slowing  2. Intermittent triphasic waves   CLINICAL CORRELATION: These findings indicate the presence moderate diffuse cerebral dysfunction. Triphasic waves are a nonspecific but pathologic finding that is seen most commonly in toxic-metabolic encephalopathies.   
